Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2003
12/31/2003CN1463696A Biological active control release microsphere and method for preparing same
12/31/2003CN1132634C Process for preparation of slow-releasing material
12/31/2003CN1132633C Pharmaceutical compositions containing gellants in form of alkyl amides of di- and tri-carboxylic acids
12/31/2003CN1132632C 缓释药物组合物 Release pharmaceutical composition
12/31/2003CN1132630C Vaccine adjuvants
12/31/2003CN1132626C Stabilised growth hormone formulation and method of preparation thereof
12/31/2003CN1132625C 包胶在透明质酸微粒中的缓释药物组合物 Hyaluronic acid particles encapsulated in a sustained-release pharmaceutical compositions
12/31/2003CN1132624C Compsns. comprising antifungal agent and acetate buffer
12/31/2003CN1132582C High-content famciclovir tablets
12/31/2003CN1132573C Long-lasting composition for rectal administration
12/31/2003CA2829581A1 Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions
12/31/2003CA2712349A1 Popping oral administration form
12/31/2003CA2493834A1 Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions
12/31/2003CA2492047A1 Short duration depot formulations
12/31/2003CA2491152A1 Oral pharmaceutical forms of liquid drugs having improved bioavailability
12/31/2003CA2490725A1 Devices and methodologies useful in body aesthetics
12/31/2003CA2490704A1 Process for producing block copolymer/drug composite
12/31/2003CA2490423A1 Buffered formulations for concentrating antibodies and methods of use thereof
12/31/2003CA2490365A1 Quick dissolve compositions and tablets based thereon
12/31/2003CA2490360A1 Pegylated factor vii glycoforms
12/31/2003CA2490354A1 Drug transport and delivery system
12/31/2003CA2490342A1 Stabilised solid compositions of factor vii polypeptides
12/31/2003CA2490341A1 Solid pharmaceutical composition containing a lipophilic active principle and preparation method thereof
12/31/2003CA2490325A1 Transdermal aerosol compositions
12/31/2003CA2490232A1 Improved compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing
12/31/2003CA2490057A1 Metastable pharmaceutical compositions
12/31/2003CA2489987A1 Fluorosiloxane matrix controlled diffusion drug delivery system
12/31/2003CA2489984A1 Pharmaceutical compositions with improved dissolution
12/31/2003CA2489949A1 Breath freshening and oral cleansing product with cinnamaldehyde
12/31/2003CA2489806A1 Liposomes containing biologically active compounds
12/31/2003CA2489561A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same
12/31/2003CA2489554A1 Actuation indicator for a dispensing device
12/31/2003CA2489528A1 Nasal compositions comprising a mucopolysaccharide and propylene glycol
12/31/2003CA2489347A1 Transdermal drug delivery system
12/31/2003CA2488942A1 Targeting system comprising uniformly-sized nanoparticles with at least one polymer and at least one positively-charged polysaccharide and preparation method thereof
12/31/2003CA2445515A1 Transcription factor modulating compounds and methods of use thereof
12/30/2003US6670455 Use of a chromatography separation processes and/or fractional precipitation
12/30/2003US6670407 Contacting a mixture of substrates or their precursors with a supercritical fluid under supercritical conditions and reduced viscosity and physical blending to plasticise and swell polymer and distribute biofunctional material
12/30/2003US6670399 Contacting a blood vessel wall cell with an A beta 40 inhibitor, such that cerebral amyloid angiopathy is inhibited
12/30/2003US6670395 Phenoxyacetic acid and/or a lower alkyl ester thereof
12/30/2003US6670384 Methods of administering epothilone analogs for the treatment of cancer
12/30/2003US6670354 Methods to enhance white blood cell count
12/30/2003US6670332 Cytofectins comprising complex amphiphilic lipids in which a bioactive agent which is recognized by biological systems is joined to a Rosenthal Inhibitor core structure through an alkyl linking group
12/30/2003US6670322 Method of targeting pharmaceuticals to motor neurons
12/30/2003US6670118 Method for treating papillomavirus infections
12/30/2003US6669966 Topically applying oxides of bismuth, cobalt, copper, iron, manganese or praseodymium, as ointments or on bandages to improve neovascularization of injuries or skin disorders
12/30/2003US6669964 Composition for solubilizing salicylic acid
12/30/2003US6669963 Stable particle in liquid formulations
12/30/2003US6669958 Gel delivery vehicles for anticellular proliferative agents
12/30/2003US6669957 Solid pills/pharmaceutical comprising paracetamol or tramadol dispersed in diluents and vinyl acetate-vinylpyrrolidinone copolymer as excipients, to form tablets having good texture and taste
12/30/2003US6669953 Transdermal patches comprising pressure sensitive adhesives for delivery fo drugs such as isosorbide mononitrate, indomethacin or ketoprofen; sustained release
12/30/2003US6669951 Using conjugate comprising the compound and a delivery-enhancing transporter wherein the compound is attached to the delivery-enhancing transporter through a linker comprising at least 5 guanidino or amidino moieties
12/30/2003US6669938 ImmunoConjucates for cancer diagnosis and therapy
12/30/2003US6669879 Method for producing solid dosing forms
12/30/2003CA2346001C Controlled release nanoparticulate compositions
12/30/2003CA2280940C Use of plant extract for inhibition of haemophilus influenzae
12/30/2003CA2273960C Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides
12/30/2003CA2221356C Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
12/30/2003CA2175971C Stable liquid composition containing urate oxidase and lyophilized composition for its preparation
12/30/2003CA2159908C Manufacturing matrices
12/30/2003CA2144416C Method and composition for the treatment of hair loss
12/30/2003CA2128421C Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders
12/30/2003CA2121358C Thymidine phosphorylase for use in the modulation of cellular proliferation or chemotaxis
12/30/2003CA2096537C Method of administering dipalmitoylphosphatidylcholine dispersions
12/30/2003CA2046089C High solids low viscosity polysaccharides
12/29/2003WO2004002469A1 Isoflavone concentrate and method for production thereof
12/29/2003CA2448513A1 Isoflavone concentrates, as well as methods for their production
12/28/2003CA2433982A1 Dietary supplements for improving kidney function
12/26/2003CA2391691A1 Modified release pharmaceutical composition containing bupropion hci as active substance
12/25/2003WO2003106495A2 MONOCLONAL ANTIBODY hPAM4
12/25/2003WO2003105888A1 Acidic insulin preparations with improved stability
12/25/2003US20030236320 Polyhydroxyalkanoate compositions having controlled degradation rates
12/25/2003US20030236310 Drug mixture with liquid polymer and polyester wax
12/25/2003US20030236309 Novel formate salt of O-desmethyl-venlafaxine
12/25/2003US20030236306 Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
12/25/2003US20030236239 In situ therapy for vision defects; photorefractive therapy
12/25/2003US20030236238 Respiratory system disorders; asthma; stable powder form of formoterol; storage stability
12/25/2003US20030236236 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
12/25/2003US20030236224 Increasing the vascular half life of starch by oxidizing and reducing the starch and administering the oxidized and reduced starch into the circulation of a mammal
12/25/2003US20030236223 For slowing tumor growth, decreasing cell proliferation, decreasing neovascularization and blocking metastatic spread
12/25/2003US20030236214 Process is described for the delivery of a therapeutic polynucleotide to a tissue suffering from or potentially suffering from ischemia
12/25/2003US20030236207 Particulate complex for administering nucleic acid into a cell
12/25/2003US20030236205 Hybridization signal amplification method (HSAM) nanostructures for diagnostic and therapeutic uses
12/25/2003US20030236203 Comprises praziquantel and/or pyrantel in solvent with thickener for improved bioavailability
12/25/2003US20030236196 Polyoxyethylene glycol-modified tumor necrosis factor for higher concentrations, decreased viscosity, and improved stability; for treatment of inflammation
12/25/2003US20030236192 Method of modifying the release profile of sustained release compositions
12/25/2003US20030236183 Comprises 5-HT4 receptor antagonists/agonists; for treatment of gastrointestinal disorders; veterinary medicine
12/25/2003US20030235643 Food intermediate having sequestered phytosteryl esters in a polysaccharide matrix
12/25/2003US20030235628 Mixtures of proton pump inhibitor such as lansoprazole and water soluble and insoluble bases, used for prophylaxis of gastrointestinal disorders; neutralization gastric juices
12/25/2003US20030235627 Applying basic drugs to skins for prophylaxis of human papillomavirus infections; skin disoders
12/25/2003US20030235626 Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses
12/25/2003US20030235618 Mixtures of acetaminophen, neutralized carbopol and polyethylene glycol having high viscocity; sweetening
12/25/2003US20030235617 Pharmaceutical dosage form for mucosal delivery
12/25/2003US20030235616 Pharmaceutical pills comprising drugs such as non-steroidal antiinflammatory agents, and cores surrounded by shells, having apertures for timed or sustained drug delivery
12/25/2003US20030235614 Time release agents comprising drugs such as tacrolimus in solid solutions
12/25/2003US20030235613 Popping oral administration form
12/25/2003US20030235611 Vesicle comprises ATP and phospholipid; fusion proteins
12/25/2003US20030235610 Liposomes containing biologically active compounds
12/25/2003US20030235598 Cosmetic or pharmaceutical preparations comprising an oxalkylated polyglycerol ester
12/25/2003US20030235596 Process for preparing a finely self-emulsifiable pharmaceutical composition
1 ... 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 ... 1712